B1 Marketing Group

B1 Marketing Group B1 Marketing Group is a tech-enabled claimant acquisition firm built for law firms.

Using proprietary software and AI-assistance, we identify and qualify injured individuals for mass tort cases - delivering the right claimants to attorneys, at scale.

The judge overseeing the federal Paraquat MDL has ordered limited discovery and depositions after an unusually large num...
06/16/2026

The judge overseeing the federal Paraquat MDL has ordered limited discovery and depositions after an unusually large number of plaintiffs declined proposed settlement offers.

Court records indicate that more than 80% to 90% of eligible claimants represented by certain law firms opted out, prompting concerns about the settlement process and plaintiff participation.

To better understand the reasons behind the high opt-out rates, the court selected a portion of those cases for additional review, including plaintiff fact sheets, depositions, and verification of exposure evidence.

The move signals increased judicial scrutiny as settlement negotiations continue in one of the nation's largest toxic tort litigations involving allegations that Paraquat exposure caused Parkinson's disease.

With thousands of cases still pending, the outcome of this discovery process could significantly influence the future direction of Paraquat settlement discussions and ongoing litigation.

A Los Angeles Superior Court judge has upheld a groundbreaking $6 million verdict against Meta and YouTube in a case inv...
06/15/2026

A Los Angeles Superior Court judge has upheld a groundbreaking $6 million verdict against Meta and YouTube in a case involving a teenage user who alleged that the platforms' addictive features contributed to depression, anxiety, and body dysmorphia.

Judge Carolyn Kuhl rejected arguments that the case focused on protected online content, ruling instead that the evidence centered on platform design features that allegedly encouraged compulsive use.

The court also upheld $3 million in punitive damages, finding substantial evidence that both companies disregarded the safety and well-being of minors.

The decision marks a significant development in the growing wave of social media addiction litigation and could influence future cases involving claims that platform design harms young users.

Johnson & Johnson’s talc litigation continues to make headlines, with more than 68,000 claims now pending and fresh cour...
06/14/2026

Johnson & Johnson’s talc litigation continues to make headlines, with more than 68,000 claims now pending and fresh court activity keeping this mass tort front and center. Recent reporting shows the battle is far from over, and the latest rulings continue to shape what comes next for plaintiffs and defense strategy alike.

When a product is part of a national headline for this long, it’s a reminder that accountability, transparency, and strong advocacy matter. The talc litigation remains one of the most closely watched product liability battles in the country.

A Los Angeles jury has awarded $32 million to the family of a California woman who died from pleural mesothelioma after ...
06/13/2026

A Los Angeles jury has awarded $32 million to the family of a California woman who died from pleural mesothelioma after years of alleged exposure to asbestos-contaminated talc products.

Jurors found Johnson & Johnson and its subsidiaries liable for the illness, marking another significant development in the ongoing talc litigation.

The verdict adds to a growing list of talc-related cases nationwide and highlights the continued legal scrutiny surrounding allegations that certain talc-based products contained asbestos.

Johnson & Johnson has maintained that its talc products are safe and has indicated it will continue to challenge such claims in court.

As talc litigation continues to evolve, this case serves as another reminder of the high stakes involved for both plaintiffs and manufacturers in one of the largest mass torts in U.S. history.

New Lyft Sexual Assault Lawsuits Can Now Be Filed Directly Into the MDL Using a Short-Form ComplaintThe U.S. District Ju...
06/12/2026

New Lyft Sexual Assault Lawsuits Can Now Be Filed Directly Into the MDL Using a Short-Form Complaint

The U.S. District Judge presiding over all Lyft sexual assault lawsuits has authorized plaintiffs to file new claims directly with the MDL court in the Northern District of California, regardless of where the plaintiff lives. Judge Rita F. Lin adopted a short-form complaint proposed by plaintiffs’ counsel, building on a master long-form complaint filed last month.

Lyft currently faces more than 50 lawsuits alleging it failed to implement basic safety measures, such as thorough background checks, in-vehicle surveillance, stronger driver monitoring, and mandatory sexual harassment training, before assaults occurred. Plaintiffs argue the company marketed its service as safe while allowing dangerous drivers to remain on the platform.

The direct-filing order streamlines case processing, reduces delays from transferring complaints between districts, and helps standardize information across claims. Each plaintiff with an existing MDL case has 14 days to submit a short-form complaint; cases transferred later must file within 14 days after service.

This procedural update comes as the MDL (MDL No. 3171, “In re: Lyft, Inc., Passenger Sexual Assault Litigation”) prepares for early “bellwether” test trials, which will help both sides gauge jury responses to evidence repeated across most cases.

Saxenda Vision-Loss Lawsuits Continue to Develop Lawsuits and legal claims involving Saxenda continue to draw attention ...
06/11/2026

Saxenda Vision-Loss Lawsuits Continue to Develop

Lawsuits and legal claims involving Saxenda continue to draw attention as plaintiffs allege the GLP-1 medication may be associated with NAION, a serious eye condition that can cause sudden vision loss.

According to recent reporting, individuals who say they experienced vision complications after using Saxenda are being reviewed by attorneys, and the claims center on allegations that Novo Nordisk did not adequately warn patients and prescribers about the risk.

Saxenda has also been included in the broader GLP-1 product-liability litigation landscape, although specific claims depend on the injury alleged and the procedural posture of each case.

Major Development in Spinal Cord Stimulator LitigationThe U.S. Judicial Panel on Multidistrict Litigation (JPML) has cen...
06/10/2026

Major Development in Spinal Cord Stimulator Litigation

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has centralized Boston Scientific spinal cord stimulator lawsuits into a new federal MDL in the Central District of California (MDL No. 3181), assigned to U.S. District Judge Josephine L. Staton.

At least 23 pending cases have been consolidated into the MDL. Plaintiffs allege device failures, lead migration, unintended electrical shocks, burns, battery issues, faulty software, and worsening pain linked to implanted Boston Scientific SCS devices. Boston Scientific opposed the MDL creation.

This consolidation is expected to streamline discovery and pretrial proceedings as the number of claims continues to grow.

Key facts for the litigation:

Only Boston Scientific cases are included; Abbott, Medtronic, and Nevro lawsuits are proceeding individually

The court is in the Central District of California (not Northern District)

No major verdicts or settlements have been reached yet; new lawsuits may still be filed

FDA reports over 80,000 adverse event filings for SCS devices since 2008, including nearly 500 deaths

Recent SCS device generations include multiple waveform options (tonic, burst, microdosing, FAST) that automatically rotate through therapies.

The Suboxone tooth decay litigation continues to move forward in federal court, with approximately 1,833 pending cases i...
06/09/2026

The Suboxone tooth decay litigation continues to move forward in federal court, with approximately 1,833 pending cases in MDL 3092 as of June 2026. The litigation, pending in the U.S. District Court for the Northern District of Ohio before Judge J. Philip Calabrese, centers on allegations that Suboxone film caused serious dental injuries and that adequate warnings were not provided.

Recent court activity shows the litigation remains in the discovery and bellwether preparation phase. Judge Calabrese has continued issuing orders related to the production of medical, dental, and pharmacy records, including show-cause and potential contempt proceedings involving noncompliant entities. No global settlement of the dental injury claims has been publicly announced, and the litigation continues progressing toward bellwether case selection and trial preparation.

For those following the litigation, the key developments are likely to continue involving discovery disputes, scheduling orders, and bellwether preparation rather than any immediate global resolution.

Olympus colonoscopy and endoscopy devices continue to face legal scrutiny as patients report serious infections allegedl...
06/08/2026

Olympus colonoscopy and endoscopy devices continue to face legal scrutiny as patients report serious infections allegedly linked to contaminated reusable scopes.

Recent lawsuits claim that certain Olympus scopes may retain harmful bacteria even after standard cleaning, and allegations suggest design flaws make certain reusable scopes difficult to fully sterilize.

Reported complications include sepsis, bloodstream infections, antibiotic-resistant "superbug" infections, organ damage, prolonged hospitalization, and in some cases, death.

Common symptoms after a colonoscopy that may indicate infection include fever, chills, abdominal pain, nausea, vomiting, fatigue, and signs that develop days or weeks after the procedure.

Recent reports indicate Olympus scope infection lawsuits are increasing in 2026 as more patients come forward.

⚖️ A major development has emerged in the ongoing Roundup litigation. The proposed $7.25 billion settlement has been tra...
06/07/2026

⚖️ A major development has emerged in the ongoing Roundup litigation. The proposed $7.25 billion settlement has been transferred from Missouri state court to the federal Roundup MDL in California before Judge Vince Chhabria.

The settlement had previously received preliminary approval in Missouri, but objectors challenged the process, arguing that the deal was designed to limit the rights of cancer victims while helping manage Monsanto's liability.

The Judicial Panel on Multidistrict Litigation (JPML) agreed that the case shares common issues with the federal Roundup MDL and ordered the transfer.

The key dispute now centers on where the settlement should be reviewed. Monsanto and the settling plaintiffs want the case returned to Missouri state court, while opponents continue to argue that the settlement deserves closer scrutiny in federal court.

Although this transfer creates an additional procedural hurdle, it does not automatically derail the settlement. The ultimate fate of the agreement remains uncertain as legal battles over jurisdiction and fairness continue.

🔍 The Roundup litigation remains one of the largest and most closely watched mass tort cases in the United States.

Address

2162 E Williams Field Road, Ste 111-B 1
Gilbert, AZ
85295

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+18003721442

Website

Alerts

Be the first to know and let us send you an email when B1 Marketing Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share